Results 201 to 210 of about 1,006,749 (357)

Genome Assembly of the Dyeing Poison Frog Provides Insights into the Dynamics of Transposable Element and Genome-Size Evolution [PDF]

C. Dittrich, Franz Hoelzl, Steve Smith, Chloe A. Fouilloux, Darren J. Parker, Lauren A. O’Connell, Lucy S. Knowles, Margaret Hughes, Ade Fewings, Gareth Morgan, Bibiana Rojas, Aaron A. Comeault   +11 more
openalex   +1 more source

Size-Factors and Size-Inheritance

Proceedings of the National Academy of Sciences, 1923
openaire   +3 more sources

Cartridge size [PDF]

British Dental Journal, 2006
openaire   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

AI-driven multi-objective optimization of FCHEV sizing and energy management considering degradation and vehicle dynamics under realistic machine learning-based traffic conditions. [PDF]

Sci Rep
Montazeri-Gh M, Mostashiri A.
europepmc   +1 more source

Differences in clutch size, egg size and larval pigmentation betweenCobitis taeniaandC. bilineata(Cobitidae) [PDF]

, 1998
Jörg Bohlen
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Hybrid reinforcement learning optimization of aging aware energy management and powertrain sizing in fuel cell hybrid electric vehicles. [PDF]

Sci Rep
Mostashiri A, Montazeri-Gh M.
europepmc   +1 more source

Truth-Tracking via Approval Voting: Size Matters

, 2022
Tahar Allouche, Jérôme Lang, Florian Yger   +2 more
openalex   +2 more sources

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source